Fåhraeus Startup & Growth AB, alongside SmiLe Inject Capital, has invested 11.2 million kronor in Yazen Health to enhance its market presence in Sweden's growing digital healthcare sector focused on weight management.
Target Information
Yazen Health, founded in Lund in 2021, is a registered healthcare provider specializing in digital weight management solutions. The company combines healthcare services from doctors, dietitians, psychologists, and personal trainers with modern pharmaceutical treatments for long-term weight loss. The founding team consists of experienced professionals, including Magnus Nyhlén, a physician and entrepreneur, Otto Bretz, CTO, Fredrik Meurling as CEO, and Martin Carlsson, an endocrinology specialist.
Yazen Health addresses an urgent need in Sweden for effective weight loss solutions that integrate medical support with lifestyle changes. The services provided by Yazen are entirely funded by the patients themselves, emphasizing the growing personal financial commitment to health improvement in the country.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Sweden
The health startup sector remains vibrant in Sweden, despite recent market fluctuations. Investors are still keen on financing innovative solutions that emerge in this landscape, particularly those that promise signif
Similar Deals
Fåhraeus Startup & Growth AB
invested in
Yazen Health
in 2022
in a Other VC deal
Disclosed details
Transaction Size: $1M